Several lines of evidence suggest that part of the defect occurring during bladder inflammation is located at the interface of urine in the bladder lumen with transitional epithelial cells lining the bladder. Not only is the subapical endosomal pathway of transitional epithelial cells disrupted structurally with vacuolization during inflammation, but in some animal models of bladder inflammation endosomal fusion reconstituted in vitro is inhibited. The most quantitatively important mediators of bladder inflammation known, neurokinin-1 (substance P) and bradykinin, both have seven transmembrane domain G-protein linked receptors present in the disrupted endosomal pathway. These receptors may be functionally important mediators of bladder inflammation as receptor antagonists largely restore the defect in endosomal fusion associated with bladder inflammation. The current application aims to fully develop or refute the hypothesis that part of the defect occurring during bladder inflammation is inhibition of endosomal fusion in the subapical endosomal pathway of transitional epithelial cells. The application seeks to define the molecular components that modulate changes in endosomal fusion in the subapical endosomal pathway. We propose to determine whether effects on endosomal fusion are a general phenomenon of bladder inflammatory models, and whether the peptides neurokinin-1 and bradykinin can reproduce these effects. The molecular mechanisms by which changes in fusion are mediated will be examined at several points in the signal transduction cascade: effects of neurokinin-1 and bradykinin-2 receptors on endosomal fusion, G-protein mediation of fusion effects, and the identity and role of the final common pathway fusion proteins such an syntaxins and VAMP's. Finally, analogs of another neurally derived peptide, somatostatin, are potently anti-inflammatory in a number of clinical settings including interstitial cystitis. We will determine if this agent with clinical potential reverses the inhibition of endosomal fusion reconstituted in vitro associated with models of bladder inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK051392-04
Application #
6177530
Study Section
Special Emphasis Panel (ZRG4-GMB (05))
Program Officer
Mullins, Christopher V
Project Start
1997-04-01
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2002-03-31
Support Year
4
Fiscal Year
2000
Total Cost
$226,264
Indirect Cost
Name
Tulane University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Saban, M R; Saban, R; Hammond, T G et al. (2002) LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol 282:F202-10
Saban, Marcia R; Nguyen, Ngoc-Bich; Hammond, Timothy G et al. (2002) Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 160:2095-110
Saban, M R; Hellmich, H; Nguyen, N B et al. (2001) Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 5:147-60
Saban, R; Saban, M R; Nguyen, N B et al. (2001) Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice. Physiol Genomics 7:35-43
Saban, M R; Nguyen, N B; Hammond, T G et al. (2001) cDNA array of lipopolysaccharide-induced bladder gene expression. Urology 57:117
Wang, X C; Saban, R; Kaysen, J H et al. (2000) Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder. J Urol 163:993-8
Saban, R; Saban, M R; Nguyen, N B et al. (2000) Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am J Pathol 156:775-80
Hammond, T G; Saban, R; Bost, K L et al. (2000) Substance P dependence of endosomal fusion during bladder inflammation. Am J Physiol Renal Physiol 278:F440-51
Burow, M E; Weldon, C B; Tang, Y et al. (1998) Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 58:4940-6
Ortiz, L A; Moroz, K; Liu, J Y et al. (1998) Alveolar macrophage apoptosis and TNF-alpha, but not p53, expression correlate with murine response to bleomycin. Am J Physiol 275:L1208-18

Showing the most recent 10 out of 11 publications